A phase I trial of weekly gemcitabine (GEM), administered as a constant dose-rate infusion, and docetaxel (DOC) in patients with advanced solid tumors (LOA-8)

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 22; no. 14_suppl; p. 2090
Main Authors Rinaldi, D. A., Lormand, N. A., Rainey, J. M., Brierre, J. E., Cole, J. L., Roden, K. B.
Format Journal Article
LanguageEnglish
Published 15.07.2004
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2004.22.14_suppl.2090